Pharmacokinetic profile in late pregnancy and cord blood concentration of tipranavir and enfuvirtide

International Journal of STD and AIDS

Volumn 22, Issue 5, 2011, Pages 294-295

  Weizsaecker, K ^a   Kurowski, M ^a   Hoffmeister, B ^a   Schurmann D ^b   Feiterna Sperling, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Charité Universitätsmedizin Berlin ^*  (Germany)

Author keywords

Antiretroviral therapy; Enfuvirtide; HIV; Mother to child transmission; Pharmacokinetics; Pregnancy; Tipranavir

Indexed keywords

ENFUVIRTIDE; LAMIVUDINE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; TIPRANAVIR; ZIDOVUDINE;

ADULT; APGAR SCORE; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; FEMALE; FETOPLACENTAL UNIT; GENE MUTATION; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; FEMALE; FETAL BLOOD; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HUMANS; PEPTIDE FRAGMENTS; PLASMA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYRIDINES; PYRONES;

EID: 79957787561     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009166     Document Type: Article

References (8)

1. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008;22:289-299
2. Wensing AMJ, Boucher CAB, van Kasteren M, van Dijken PJ, Geelen SP, Juttmann JR. Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir. AIDS 2006;20:1465-1467
3. Boehringer Ingelheim International GmbH. Aptivusw (tipranavir) Capsules - Summary of Product Characteristics (SPC), 2007
4. Gingelmaier A, Kurowski M, Kästner R, et al. Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery. AIDS 2006;20:1737-1743
5. Ripamonti D, Cattaneo D, Maggiolo F, et al. Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer. AIDS 2007;21:2409-2415
6. Meyohas MC, Lacombe K, Carbonne B, Morand-Joubert L, Girard PM. Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough. AIDS 2004;18:1966-1968
7. Brennan-Benson P, Pakianathan M, Rice P, et al. Enfuvirtide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta. AIDS 2006;20:297-299
8. Ceccaldi PF, Ferreira C, Gavard L, Gil S, Peytavin G, Mandelbrot L. Placental transfer of enfuvirtide in the ex vivo human placenta perfusion model. Am J Obstet Gynecol 2008;198:433. e1-e2